News

In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...
Spikevax has been fully approved for children ages 6 months through 11 years with high-risk conditions. HealthDay News — Moderna’s COVID-19 vaccine has received full approval from the U.S. Food and ...